Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0002 Transporter Info | ||||
| Gene Name | ABCC2 | ||||
| Transporter Name | Multidrug resistance-associated protein 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Saquinavir Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 441243 | ||||
| Docking Score | -13.041 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C38H50N6O5 | ||||
| Molecular Weight | 670.8 | ||||
| Canonical SMILES |
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
|
||||
| InChI |
InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1
|
||||
| InChIKey | QWAXKHKRTORLEM-UGJKXSETSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.2 | Rotatable Bond Count | 13 | |
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Cefoperazone Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 44187 | ||||
| Docking Score | -12.917 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C25H27N9O8S2 | ||||
| Molecular Weight | 645.7 | ||||
| Canonical SMILES |
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O
|
||||
| InChI |
InChI=1S/C25H27N9O8S2/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41)/t15-,16-,22-/m1/s1
|
||||
| InChIKey | GCFBRXLSHGKWDP-XCGNWRKASA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.7 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 13 | ||
| Xenobiotic Name | Midecamycin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5282169 | ||||
| Docking Score | -12.452 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C41H67NO15 | ||||
| Molecular Weight | 814 | ||||
| Canonical SMILES |
CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C
|
||||
| InChI |
InChI=1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1
|
||||
| InChIKey | DMUAPQTXSSNEDD-QALJCMCCSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.6 | Rotatable Bond Count | 14 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 16 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.